131 related articles for article (PubMed ID: 17987014)
1. Microarrays: retracing steps.
Coombes KR; Wang J; Baggerly KA
Nat Med; 2007 Nov; 13(11):1276-7; author reply 1277-8. PubMed ID: 17987014
[No Abstract] [Full Text] [Related]
2. Multiple gene signatures aim to qualify risk in breast cancer.
Tuma RS
J Natl Cancer Inst; 2005 Mar; 97(5):332. PubMed ID: 15741566
[No Abstract] [Full Text] [Related]
3. Trial and error: prognostic gene signature study design altered.
Tuma RS
J Natl Cancer Inst; 2005 Mar; 97(5):331-3. PubMed ID: 15741565
[No Abstract] [Full Text] [Related]
4. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
5. Genomic medicine. Gene expression tests foretell breast cancer's future.
Garber K
Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
[No Abstract] [Full Text] [Related]
6. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
7. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
8. The use of microarray technology in the management of breast cancer.
Pusztai L
Clin Adv Hematol Oncol; 2007 Mar; 5(3):193-4, 197. PubMed ID: 17519880
[No Abstract] [Full Text] [Related]
9. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
10. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
11. Gene expression predictors in breast cancer: current status, limitations and perspectives.
Desmedt C; Ruíz-García E; André F
Eur J Cancer; 2008 Dec; 44(18):2714-20. PubMed ID: 18977656
[TBL] [Abstract][Full Text] [Related]
12. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
[TBL] [Abstract][Full Text] [Related]
13. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
14. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
Guay D; Evoy AA; Paquet E; Garand C; Bachvarova M; Bachvarov D; Lebel M
Int J Biochem Cell Biol; 2008; 40(11):2492-507. PubMed ID: 18571458
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.
Andreopoulou E; Hortobagyi GN
J Clin Oncol; 2008 Aug; 26(22):3660-2. PubMed ID: 18669447
[No Abstract] [Full Text] [Related]
16. Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.
Miller WR; Larionov A; Renshaw L; Anderson TJ; Walker JR; Krause A; Sing T; Evans DB; Dixon JM
J Clin Oncol; 2009 Mar; 27(9):1382-7. PubMed ID: 19224856
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].
Diallo-Danebrock R; Ting E; Gluz O; Herr A; Mohrmann S; Geddert H; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2007; 91():187-96. PubMed ID: 18314614
[TBL] [Abstract][Full Text] [Related]
18. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
Pennanen PT; Sarvilinna NS; Ylikomi TJ
Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy for breast cancer].
Miki Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():522-5. PubMed ID: 16416846
[No Abstract] [Full Text] [Related]
20. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
